1. |
Cohen JI, Kimura H, Nakamura S, et al. Epstein-Barr virus-associated lymphoproliferative disease in non-immunocompromised hosts: a status report and summary of an international meeting, 8-9 September 2008[J]. Ann Oncol, 2009, 20(9): 1472-1482.
|
2. |
Swerdlow SH, Campo E, Harris NL, et al. WHO Classification of Tumours of Haematopoietic and Lymphoid Tissues[M]. Lyon: IARC, 2008: 278-280.
|
3. |
Kimura H, Ito Y, Kawabe S, et al. EBV-associated T/NK-cell lymphoproliferative diseases in nonimmunocompromised hosts: prospective analysis of 108 cases[J]. Blood, 2012, 119(3): 673-686.
|
4. |
Abdul-Ghafar J, Kim JW, Park KH, et al. Fulminant Epstein-Barr virus-associated T-cell lymphoproliferative disorder in an immunocompetent middle-aged man presenting with chronic diarrhea and gastrointestinal bleeding[J]. J Korean Med Sci, 2011, 26(8): 1103-1107.
|
5. |
Park S, Kim K, Kim WS, et al. Systemic EBV+ T-cell lymphoma in elderly patients: comparison with children and young adult patients[J]. Virchows Arch, 2008, 453(2): 155-163.
|
6. |
Isobe Y, Aritaka N, Setoguchi Y, et al. T/NK cell type chronic active EpsteineBarr virus disease in adults: an underlying condition for EpsteineBarr virus-associated T/NK-cell lymphoma[J]. J Clin Pathol, 2012, 65(3): 278-282.
|
7. |
郑晓丹, 周小鸽, 金 妍, 等. 成年人系统性EB病毒阳性T/NK细胞淋巴组织增殖性疾病的临床病理研究[J]. 中华病理学杂志, 2011, 40(4): 227-234.
|
8. |
Ohshima K, Kimura H, Yoshino T, et al. Proposed categorization of pathological states of EBV-associated T/natural killer-cell lymphoproliferative disorder (LPD) in children and young adults: overlap with chronic active EBV infection and infantile fulminant EBV T-LPD[J]. Pathol Int, 2008, 58(4): 209-217.
|
9. |
Lee YJ, Yang SK, Byeon JS, et al. Analysis of colonoscopic findings in the differential diagnosis between intestinal tuberculosis and Crohn’s disease[J]. Endoscopy, 2006, 38(6): 592-597.
|
10. |
渡部优子, 高桥真由美, 三浦修, 等.成人EB病毒阳性T/NK细胞淋巴组织增殖性疾病的临床特征及化疗效果[C].第20届EB病毒感染性疾病研究会学术会议论文汇编, 东京, 2010. 东京: EB病毒感染性疾病研究会, 2010.
|
11. |
Arai A, Imadome K, Watanabe Y, et al. Clinical features of adult-onset chronic active Epstein-Barr virus infection: a retrospective analysis[J]. Int J Hematol, 2011, 93(5): 602-609.
|
12. |
Kawa K, Sawada A, Sato M, et al. Excellent outcome of allogeneic hematopoietic SCT with reduced-intensity conditioning for the treatment of chronic active EBV infection[J]. Bone Marrow Transplant, 2011, 46(1): 77-83.
|